Manojkumar Shah Jashwantlal

Manojkumar Shah Jashwantlal

Active Director Director DIN 05266030
DIN 05266030 First appointment Jul 2005 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2005
Shareholding value •••• Premium profile

About Manojkumar Shah Jashwantlal

Data last updated:

Manojkumar Shah Jashwantlal is a Director at Puniska Industries Private Limited (since 2017), Director at Puniska Injectables Private Limited (since 2022) and Whole-Time Director at Pride Drugs And Pharma Private Limited (since 2005), and holds 1 more current directorship. The companies operate in Trading and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹571 Cr; the largest is Puniska Industries Private Limited at ₹334 Cr (FY 2025). Earlier, Manojkumar Shah Jashwantlal was a Director at Puniska Healthcare Private Limited (2018–2021).

DIN 05266030
Primary Designation Director
Industry Trading
First Appointment 22 Jul 2005
Oldest Company Age 21 yrs
Largest company Puniska Industries Private Limited · ₹334 Cr (FY 2025)
Combined revenue ₹571 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Puniska Industries Private Limited U51909GJ2017PTC096584
Director24 May 20172017₹334 Cr (FY 2025)Active
Puniska Injectables Private Limited U24230GJ2022PTC132016
Director15 Jun 20222022₹170 Cr (FY 2025)Active
Whole-Time Director22 Jul 20052005₹66.89 Cr (FY 2025)Active
Puniska Healthcare Private Limited U21002GJ2025PTC169717
Director24 Nov 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Puniska Healthcare Private Limited U36999GJ2017PTC098441
Director12 Mar 20182017₹61.99 Cr (FY 2022)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pride Drugs And Pharma Private Limited
Puniska Industries Private Limited
Puniska Healthcare Private Limited
Puniska Injectables Private Limited
Premium access

Shareholding and investment profile for Manojkumar Shah Jashwantlal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manojkumar Shah Jashwantlal

Manojkumar Shah Jashwantlal currently holds 4 directorships: Puniska Industries Private Limited (Director, since 24 May 2017, revenue ₹334 Cr (FY 2025)); Puniska Injectables Private Limited (Director, since 15 Jun 2022, revenue ₹170 Cr (FY 2025)); Pride Drugs And Pharma Private Limited (Whole-Time Director, since 22 Jul 2005, revenue ₹66.89 Cr (FY 2025)); Puniska Healthcare Private Limited (Director, since 24 Nov 2025).

Manojkumar Shah Jashwantlal was first appointed on 22 Jul 2005 as Whole-Time Director at Pride Drugs And Pharma Private Limited. The most recent appointment on record is 24 Nov 2025 at Puniska Healthcare Private Limited.

The 3 current companies of Manojkumar Shah Jashwantlal that report revenue have a combined latest revenue of ₹571 Cr: Puniska Industries Private Limited ₹334 Cr (FY 2025); Puniska Injectables Private Limited ₹170 Cr (FY 2025); Pride Drugs And Pharma Private Limited ₹66.89 Cr (FY 2025).

Manojkumar Shah Jashwantlal held 1 earlier board appointment: Puniska Healthcare Private Limited (Director, 12 Mar 2018 to 02 Nov 2021).

The current boards of Manojkumar Shah Jashwantlal's companies include Kalpesh Ambubhai Patel (Puniska Industries Private Limited), Maheshkumar Bhagwansingh Yadav (Puniska Industries Private Limited), Punitaben Kalpeshbhai Patel (Puniska Industries Private Limited), Neha Verma (Puniska Injectables Private Limited), Neha Verma (Puniska Injectables Private Limited), Jigar Vyas (Pride Drugs And Pharma Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available